Condition
Early Osteoarthritis
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 1 (1)
Trial Status
Completed2
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07332182Not ApplicableNot Yet Recruiting
MaioRegen Prime Study for the Treatment of Deep Osteochondral Lesion of the Knee
NCT04267510CompletedPrimary
Clinical and Molecular Aspects of Early Osteoarthritis
NCT01747018Phase 1Completed
Platelet Rich Plasma Injection for Knee Pain
Showing all 3 trials